this is my bullish trend continue idea. however wait for come key level after how to respect to key level after trend continue to up trend you can entry ,so this is my opinion only .
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes drugs in areas of unmet medical need such as human immunodeficiency virus (HIV) in the United States, Europe and internationally.
Revenue TTM 27.3B
Net Income TTM 6.2B
EBITDA TTM 12.5B
Debt/EBITDA TTM 2.5x
EBITDA Margin 45.9%
Net Margin 22.8%
this is my bullish trend continue idea. however wait for come key level after how to respect to key level after trend continue to up trend you can entry ,so this is my opinion only .
Nice box testing the 250h.
The 50h and the 21h want to move on the right order after this pullback.
The previous high can be a target, while a breakdown has more targets.
The PEAD projected a Bullish outlook for $GILD after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 33.33%.
Indeed. B Wave in a zigzag form appears to be completed. We are going down to one extent to another.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line....
The PEAD projected a Bullish outlook for $GILD after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%.
Buy (Entry Price) above the black line and exit (Stop Loss) below the red line. Can take profit at the suggested Target Price.
Entry Price: $61.83
Target Price: $62.45
Stop Loss: $61.21
Short (Entry Price) below the black line and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price.
Entry Price: $58.87
Target Price: $58.47
Stop Loss: $59.54
The PEAD projected a Bullish outlook for $GILD after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 62.5%.
NASDAQ:GILD
Early Long Idea on Gilead Sciences
Gilead has navigated 2/3rds of a huge arc that has been forming since 2015, and the arc is beginning to slope vertical.
Price navigated the yellow pitchfork on the way down, and now is beginning to be directed by the purple upsloping fork.
Weekly Stoch RSI is approaching oversold levels.
I will wait for a...
I believe Gilead has made it's final low on Oct 29th. These Wyckoff accumulation patterns are very powerful reversal patterns. I will be more convinced if price breaks above the red line resistance. If that that happens, , I will start adding GILD on my portfolio. Good luck everyone
